Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative study

Table 2 Demographic characteristics of interviewed participants

Characteristic	n = 34^a
Age, years
30–39	4
40–49	9
50–59	5
60–69	9
70–79	6
80 +	1
Gender
Female	8
Area of expertise
Infectious disease	10
Public/Community health	9
General medicine	7
Bioethics	3
Ophthalmology	3
Nutrition	2
Nationality
USA	13
UK	5
Uganda	2
Tanzania	2
Nigeria	2
Pakistan	2
France	1
Norway	1
Finland	1
Sweden	1
Burkina Faso	1
Ethiopia	1
Bangladesh	1
Australia	1
Stakeholder type^b
Investigator	17
Funder	7
Intergovernmental organization	4
Bioethicist	4
Institutional Review Board or Research Ethics Committee member	3
Data Safety and Monitoring Committee member	3
Community health expert	2
Local community member	2
Government official	1
Industry	1

^a34/35 Interviewees are represented in this table. One interview with a group of individuals from a national research ethics committee where mass drug administration has occurred is not included
^bFor stakeholder type, n > 35 because some participants could be classified as more than one stakeholder type

ISSN: 2049-9957